CellCarta Cuts Regulatory Review Time by 9 Hours Weekly with RegASK AI

Event summary

  • CellCarta and RegASK completed a year-long collaboration to automate regulatory monitoring, reducing review time from up to 9 hours weekly to near real-time.
  • The partnership created a centralized regulatory intelligence hub that consolidates and contextualizes global regulatory signals.
  • CellCarta plans to expand AI use for tasks like content curation, impact assessment, and stakeholder collaboration.
  • RegASK's platform achieved ISO/IEC 42001 certification for AI Management Systems.

The big picture

The partnership highlights the growing pressure on CROs to manage regulatory complexity through AI automation. As global regulations proliferate, companies that can reduce manual monitoring and surface actionable insights faster will gain a competitive edge in drug development timelines. This trend is particularly critical in precision medicine, where regulatory delays can significantly impact market access.

What we're watching

AI Adoption Pace
How quickly CellCarta and similar CROs will deploy agentic AI across their regulatory workflows.
Regulatory Complexity
Whether AI-driven platforms can keep up with the accelerating volume and fragmentation of global regulations.
Competitive Differentiation
The extent to which automated regulatory intelligence becomes a key differentiator in the CRO market.

Related topics

Partnership